miRNA sequencing from routine colonic biopsies reveals an enrichment of submucosal hsa-miRNA-486-5p in Parkinson’s disease
Objective: In the present work, we aimed to investigate the expression of microRNAs (miRNAs) in routine colonic biopsies obtained from patients with idiopathic Parkinson's disease…Deposition of phosphorylated α-synuclein in the muscularis externa of the gastrointestinal tract in patients with prodromal Parkinson’s disease
Objective: In the present study, we investigated Lewy pathology in the enteric nervous system (ENS) of seven Parkinson’s disease (PD) patients who underwent a gastrectomy,…Sex-related disease differences in Parkinson’s disease
Objective: To highlight differences in clinical disease parameters between sexes in a cohort of Parkinson’s disease (PD) patients. Background: PD is a progressive neurodegenerative disorder…Dietary insights of Parkinson’s Disease patients
Objective: To report on the patterns of nutritional intake in an Australian Parkinson’s disease (PD) cohort. Background: There is limited information about the dietary habits…Intestinal nerve damage and gut dysfunction in mouse models of Parkinson’s Disease
Objective: This work aims to investigate gut dysfunction and enteric neuropathy in several mouse models of PD to provide insight into enteric nervous system (ENS)…Gut microbiota in Parkinson disease with mild cognition impairment in a southern Chinese cohort.
Objective: The aim of this study was to compare the structure of gut microbiota and short-chain fatty acid(SCFAs) in PD with mild cognitive impairment (PD-MCI),…Dysbiosis of Gut Microbiota in a selected population of Italian Parkinson’s Disease patients
Objective: Our main objective was to investigate dysbiosis of gut microbiota in a selected population of Parkinson’s disease (PD) patients from center-south of Italy, examining…The Level of Neuroendocrine Hormones in Parkinson´s Disease and their Potential Role as Biomarkers : A Pilot Study
Objective: To elucidate the role of neuroendocrine hormones in Parkinson’s disease (PD) and evaluate their potential utilization as biomarkers. Background: A growing body of evidence,…Gastrointestinal symptoms as a risk factor for the appearance of motor fluctuations in patients with advanced Parkinson disease
Objective: Gastrointestinal alterations in patients with Parkinson`s Disease (EP) provoke alterations in the absorption of levodopa that facilitates the development of motor fluctuations. Study the…Clostridium Difficile Infection and Risk of Parkinson’s Disease: A Swedish Population-Based Cohort Study
Objective: To examine whether individuals with a history of Clostridium difficile (C. diff) infection have an elevated risk of developing Parkinson’s disease (PD). Background: The…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 11
- Next Page »